A Feasibility Study of Prophylactic White Blood Cell Transfusions

PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

September 20, 2013

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
Leukemia
Interventions
PROCEDURE

White Blood Cell Transfusion

Patient receives white blood cells by vein from a volunteer donor. Each transfusion will take anywhere from 1 hour to several hours, depending on how treatment tolerated. Transfusion received every 3-4 days (at least 2 a week) for up to 6 weeks.

Trial Locations (1)

77030

University of Texas MD Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER

NCT01932710 - A Feasibility Study of Prophylactic White Blood Cell Transfusions | Biotech Hunter | Biotech Hunter